β-Arrestins as potential therapeutic targets for alzheimer's disease

Molecular Neurobiology

Volumn 48, Issue 3, 2013, Pages 812-818

  Jiang, Teng ^a   Yu, Jin Tai ^a,b,c   Tan, Meng Shan ^c   Zhu, Xi Chen ^a   Tan, Lan ^a,b,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b QINGDAO UNIVERSITY   (China)

^c OCEAN UNIVERSITY OF CHINA   (China)

Author keywords

Alzheimer's disease; A ; Therapy; arrestin; secretase

Indexed keywords

BETA ARRESTIN 1; BETA ARRESTIN 2; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; MESSENGER RNA; TAU PROTEIN;

ALLERGIC ASTHMA; ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BRAIN; BRAIN CORTEX; CARDIOVASCULAR DISEASE; CELLULAR DISTRIBUTION; CORPUS STRIATUM; DISEASE COURSE; DRUG TARGETING; ENDOCYTOSIS; FIBROBLAST; HIPPOCAMPUS; HUMAN; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OBESITY; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; RHEUMATOID ARTHRITIS; THALAMUS;

ALZHEIMER DISEASE; ANIMALS; ARRESTINS; BRAIN; HUMANS; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY;

EID: 84888008865     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-013-8469-8     Document Type: Review

References (47)

1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580):353-356. doi: 10.1126/science.1072994
2. Thathiah A, De Strooper B (2011) The role of G protein-coupled receptors in the pathology of Alzheimer's disease. Nat Rev Neurosci 12(2):73-87. doi: 10.1038/nrn2977
3. Yu NN, Wang XX, Yu JT, Wang ND, Lu RC, Miao D, Tian Y, Tan L (2010) Blocking beta2-adrenergic receptor attenuates acute stress-induced amyloid beta peptides production. Brain Res 1317:305-310. doi: 10.1016/j.brainres.2009.12.087
4. Yu JT, Tan L, Ou JR, Zhu JX, Liu K, Song JH, Sun YP (2008) Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility. Brain Res 1210:216-222. doi: 10.1016/j.brainres.2008.03.019
5. Yu JT, Wang ND, Ma T, Jiang H, Guan J, Tan L (2011) Roles of beta-adrenergic receptors in Alzheimer's disease: implications for novel therapeutics. Brain Res Bull 84(2):111-117. doi: 10.1016/j.brainresbull.2010.11. 004
6. Liu X, Zhao X, Zeng X, Bossers K, Swaab DF, Zhao J, Pei G (2013) beta-Arrestin1 regulates gamma-secretase complex assembly and modulates amyloid-beta pathology. Cell Res 23(3):351-365. doi: 10.1038/cr.2012.167
7. Thathiah A, Horre K, Snellinx A, Vandewyer E, Huang Y, Ciesielska M, De Kloe G, Munck S, De Strooper B (2013) beta-arrestin 2 regulates Abeta generation and gamma-secretase activity in Alzheimer's disease. Nat Med 19(1):43-49. doi: 10.1038/nm.3023
8. Wolfe MS (2013) Alzheimer's gamma-secretase under arrestin. Nat Med 19(1):22-24. doi: 10.1038/nm.3053
9. Wood H (2013) Alzheimer disease: Arrestin' Alzheimer disease progression? beta-arrestin 2 is a potential therapeutic target. Nat Rev Neuro 9(2):60. doi: 10.1038/nrneurol.2012.278
10. Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7(4):339-357. doi: 10.1038/nrd2518
11. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69:483-510. doi: 10.1146/annurev.ph.69.013107.100021
12. Shenoy SK, Lefkowitz RJ (2011) beta-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 32(9):521-533. doi: 10.1016/j.tips.2011.05.002
13. Shukla AK, Xiao K, Lefkowitz RJ (2011) Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling. Trends Biochem Sci 36(9):457-469. doi: 10.1016/j.tibs.2011.06.003
14. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179-197. doi: 10.1146/annurev.pharmtox.010909.105800
15. Gurevich EV, Benovic JL, Gurevich VV (2002) Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development. Neuroscience 109(3):421-436
16. Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, Kruse CG, Verhaagen J, Swaab DF (2010) Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease. Brain: J Neurol 133(Pt 12):3699-3723. doi: 10.1093/brain/awq258
17. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2011) Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225(1):54-62. doi: 10.1002/path.2912
18. De Strooper B (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 38(1):9-12
19. Flight MH (2009) Orphan receptor coupled to Abeta production. Nat Rev Drug Discov 8(4):276. doi: 10.1038/nrd2858
20. Ni Y, Zhao X, Bao G, Zou L, Teng L, Wang Z, Song M, Xiong J, Bai Y, Pei G (2006) Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat Med 12(12):1390-1396. doi: 10.1038/nm1485
21. Teng L, Zhao J, Wang F, Ma L, Pei G (2010) A GPCR/secretase complex regulates beta- and gamma-secretase specificity for Abeta production and contributes to AD pathogenesis. Cell Res 20(2):138-153. doi: 10.1038/cr.2010.3
22. Wang D, Yuen EY, Zhou Y, Yan Z, Xiang YK (2011) Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons. J Biol Chem 286(36):31852-31863. doi: 10.1074/jbc.M111.244335
23. Pontrello CG, Sun MY, Lin A, Fiacco TA, DeFea KA, Ethell IM (2012) Cofilin under control of beta-arrestin-2 in NMDA-dependent dendritic spine plasticity, long-term depression (LTD), and learning. Proc Natl Acad Sci U S A 109(7):E442-451. doi: 10.1073/pnas.1118803109
24. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS (2000) Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275(22):17201-17210. doi: 10.1074/jbc.M910348199
25. Jiang T, Yu JT, Tan L (2012) Novel disease-modifying therapies for Alzheimer's disease. J Alzheim Dis: JAD 31(3):475-492. doi: 10.3233/JAD-2012- 120640
26. Wang D, Fu Q, Zhou Y, Xu B, Shi Q, Igwe B, Matt L, Hell JW, Wisely EV, Oddo S, Xiang YK (2013) beta2 Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models. J Biol Chem 288(15):10298-10307. doi: 10.1074/jbc.M112.415141
27. Cameron B, Landreth GE (2010) Inflammation, microglia, and Alzheimer's disease. Neurobiol Dis 37(3):503-509. doi: 10.1016/j.nbd.2009.10.006
28. Walker JK, Fong AM, Lawson BL, Savov JD, Patel DD, Schwartz DA, Lefkowitz RJ (2003) Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest 112(4):566-574. doi: 10.1172/JCI17265
29. Hollingsworth JW, Theriot BS, Li Z, Lawson BL, Sunday M, Schwartz DA, Walker JK (2010) Both hematopoietic-derived and non-hematopoietic-derived {beta}-arrestin-2 regulates murine allergic airway disease. Am J Respir Cell Mol Biol 43(3):269-275. doi: 10.1165/rcmb.2009-0198OC
30. Rafei M, Berchiche YA, Birman E, Boivin MN, Young YK, Wu JH, Heveker N, Galipeau J (2009) An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. J Immunol 183(3):1759-1766. doi: 10.4049/jimmunol.0900523
31. Zhuang LN, Hu WX, Xin SM, Zhao J, Pei G (2011) Beta-arrestin-1 protein represses adipogenesis and inflammatory responses through its interaction with peroxisome proliferator-activated receptor-gamma (PPARgamma). J Biol Chem 286(32):28403-28413. doi: 10.1074/jbc.M111.256099
32. Vroon A, Lombardi MS, Kavelaars A, Heijnen CJ (2003) Changes in the G-protein-coupled receptor desensitization machinery during relapsing- progressive experimental allergic encephalomyelitis. J Neuroimmunol 137(1-2):79-86
33. Tsutsui S, Vergote D, Shariat N, Warren K, Ferguson SS, Power C (2008) Glucocorticoids regulate innate immunity in a model of multiple sclerosis: reciprocal interactions between the A1 adenosine receptor and beta-arrestin-1 in monocytoid cells. FASEB J: Off Publ Fed Am Soc Exp Biol 22(3):786-796. doi: 10.1096/fj.07-9002com
34. Kohno H, Sakai T, Saito S, Okano K, Kitahara K (2007) Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin. Exp Eye Res 84(3):569-576. doi: 10.1016/j.exer.2006.11.011
35. Selkoe DJ (2011) Resolving controversies on the path to Alzheimer's therapeutics. Nat Med 17(9):1060-1065. doi: 10.1038/nm.2460
36. Pamren A, Wanngren J, Tjernberg LO, Winblad B, Bhat R, Naslund J, Karlstrom H (2011) Mutations in nicastrin protein differentially affect amyloid beta-peptide production and Notch protein processing. J Biol Chem 286(36):31153-31158. doi: 10.1074/jbc.C111.235267
37. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R (1999) A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398(6727):518-522. doi: 10.1038/19083
38. Milano J, McKay J, Dagenais C, Foster-Brown L, Pognan F, Gadient R, Jacobs RT, Zacco A, Greenberg B, Ciaccio PJ (2004) Modulation of notch processing by gamma-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol Sci: Off J Soc Toxicol 82(1):341-358. doi: 10.1093/toxsci/kfh254
39. Wong GT, Manfra D, Poulet FM, Zhang Q, Josien H, Bara T, Engstrom L, Pinzon-Ortiz M, Fine JS, Lee HJ, Zhang L, Higgins GA, Parker EM (2004) Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 279(13):12876-12882. doi: 10.1074/jbc.M311652200
40. Wolfe MS (2012) gamma-Secretase as a target for Alzheimer's disease. Adv Pharmacol 64:127-153. doi: 10.1016/B978-0-12-394816-8.00004-0
41. Bittner T, Fuhrmann M, Burgold S, Jung CK, Volbracht C, Steiner H, Mitteregger G, Kretzschmar HA, Haass C, Herms J (2009) Gamma-secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway. J Neurosci: Off J Soc Neurosci 29(33):10405-10409. doi: 10.1523/JNEUROSCI.2288-09.2009
42. Dewachter I, Reverse D, Caluwaerts N, Ris L, Kuiperi C, Van den Haute C, Spittaels K, Umans L, Serneels L, Thiry E, Moechars D, Mercken M, Godaux E, Van Leuven F (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci: Off J Soc Neurosci 22(9):3445-3453
43. Saura CA, Chen G, Malkani S, Choi SY, Takahashi RH, Zhang D, Gouras GK, Kirkwood A, Morris RG, Shen J (2005) Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. J Neurosci: Off JX Soc Neurosci 25(29):6755-6764. doi: 10.1523/JNEUROSCI.1247-05. 2005
44. Mitani Y, Yarimizu J, Saita K, Uchino H, Akashiba H, Shitaka Y, Ni K, Matsuoka N (2012) Differential effects between gamma-secretase inhibitors and modulators on cognitive function in amyloid precursor protein-transgenic and nontransgenic mice. J Neurosci: Off J Soc Neurosci 32(6):2037-2050. doi: 10.1523/JNEUROSCI.4264-11.2012
45. Whalen EJ, Rajagopal S, Lefkowitz RJ (2011) Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol Med 17(3):126-139. doi: 10.1016/j.molmed.2010.11.004
46. Gurevich EV, Benovic JL, Gurevich VV (2004) Arrestin2 expression selectively increases during neural differentiation. J Neurochem 91(6):1404-1416. doi: 10.1111/j.1471-4159.2004.02830.x
47. Li Y, Li H, Liu X, Bao G, Tao Y, Wu Z, Xia P, Wu C, Li B, Ma L (2009) Regulation of amygdalar PKA by beta-arrestin-2/phosphodiesterase-4 complex is critical for fear conditioning. Proc Natl Acad Sci U S A 106(51):21918-21923. doi: 10.1073/pnas.0906941106